Blood Processing Devices and Consumables Industry, Development, Growth and Demand Forecast to 2020

Increasing infections and related diseases due to blood transfusion and blood donation are some of the major concerns in healthcare arena. Infectious diseases through blood transfusions occur due to the presence of microorganism, such as bacteria, virus and others parasites, in blood of donors which reach to receivers and infect their blood. Hepatitis and Acquired Immunodeficiency Syndrome (AIDS) are some of the major infectious diseases which pose great challenge to healthcare providers for the prevention and treatment of these diseases. To overcome this problem, various blood processing devices and blood processing consumables are used to prevent infection in blood transfusion and blood donation procedures. Blood processing devices are used in cell processing, blood refrigeration and centrifugation of blood cells. Blood processing consumables are used in collection of blood and grouping by various reagents.

For More Information Visit: https://www.psmarketresearch.com/market-analysis/blood-processing-devices-and-consumables-market

The global blood processing devices and consumables market is segmented into blood processing devices and blood processing consumables. Blood processing devices segment is further sub-segmented into hematocrit centrifuges, blood bank refrigerators and blood grouping analyzers, blood bank freezers, blood warmers and blood cell processors. Blood processing consumables segment includes blood bags, blood administration sets, sedimentation tubes, blood collection tubes, blood collection needles, blood grouping reagents, coagulation reagents, vials, microscopic slides, hematology reagents, slide stainer, blood lancets, blood filters and test tube racks.

North America dominates the global blood processing devices and consumables market followed by Europe. This is due to increased awareness, developed economies and increased government support in the region. In addition, high disposable incomes and favorable reimbursement policies are also supporting in the growth of blood processing devices and consumables market in the region. The U.S., followed by Canada, is the largest market for blood processing devices and consumables in North America. Germany, France and the U.K. are some of the largest markets for blood processing devices and consumables market in Europe. However, Asia-Pacific represents the fastest growing region in the global blood processing devices and consumables market. This is due to increasing awareness and rising demand of blood and blood components for blood transfusion in the region. In addition, raising population and various government initiatives are also supporting the growth of blood processing devices and consumables market in Asia. Government initiatives and campaigns in countries, such as India and China, are trying to educate people about safe blood donations and transfusions procedures. This would develop opportunity for blood processing devices and consumable market in Asia.

Request for Table of Content: https://www.psmarketresearch.com/enquiry-form.php?enqid=81&title=TOC

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication.  Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Advertisements

Global Enteral Nutrition Market Analysis, Development, Growth and Demand Forecast to 2022

The global enteral nutrition market was valued at $12,300.0 million in 2015, and it is expected to grow at a CAGR of 5.8% during 2016 – 2022. The factors driving the growth of the global market include increasing geriatric population, lower cost of enteral nutrition products, surge in the number of victims of malnutrition receiving treatment, high number of premature births and increasing incidence of cancer and central nervous system diseases. Enteral nutrition products are considered to be one of the best alternatives during the treatment of cancer and CNS diseases, to avoid nutrition deficiency in human body for optimal functioning of various organs. Cancer can change the metabolism of nutrient uptake in patient’s body, therefore they require good nutrition. Cancer may lead to malnutrition and weight loss; therefore, patients are required continuous nutrient feeding. Enteral nutrition is one of the best solutions to the problem. According to the WHO, there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 globally. The organization also reported that 57% (8 million) of new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases occurred in the less developed regions.

Explore Full Report at: https://www.psmarketresearch.com/market-analysis/enteral-nutrition-market

Enteral Nutrition Market

Similarly, the patients with CNS diseases also need proper intake of nutrients; therefore supporting the demand for enteral nutrition products. Now-a-days, various enteral nutrition products are available in the market. With the growing awareness about the association between health and nutrition, the benefits of nutritional products in the recovering process and their cost-effectiveness is driving the growth of the enteral nutrition market.

Browse Related Research: https://www.psmarketresearch.com/industry-report/consumer-products

In 2015, Asia-Pacific held the largest share in the global enteral nutrition market with 34.1% share. The enteral nutrition market in the region is anticipated to witness the highest growth at a CAGR of 7.0% during the forecast period. The increasing birth rate, along with growing geriatric population and high number of people having malnutrition is driving the growth of the enteral nutrition market in the region. The total number of people aged 65 years and above in Asia-Pacific was estimated at 288.0 million in 2010. This number is expected to reach 911.0 million by 2050. Japan has the largest old age population in Asia-Pacific. It is expected that one out of 2.5 people in Japan would be over 60 years by 2050.

Some of the major players operating in the global enteral nutrition market include Baxter International Inc., Abbott Laboratories, B. Braun Melsungen AG, Nestlé S.A., Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, and Perrigo Company Plc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Home Healthcare Industry, Analysis, Development and Demand Forecast to 2020

The global home healthcare market is growing significantly due to technological advancement and new healthcare services in the industry. Massive unexplored market in home healthcare industry of developing economies and cost effective alternatives to other modalities and facility based care are creating ample opportunities for the home healthcare market to grow at a considerable rate in the coming years. The advanced research and development facilities and new product developments by the companies are supporting to address the demand for cost effective healthcare in the home healthcare industry.

Explore More About Home Healthcare Market: https://www.psmarketresearch.com/market-analysis/home-healthcare-market

In healthcare industry, there is a trend of significant shift of treatment from hospitals to home in order to reduce healthcare expenditure. The massive global problem in the modern society is the increasing chronic diseases, such as stroke, kidney diseases and hypertension. According to Centers for Disease Control and Prevention, as of 2012 approximately 117 million U.S. people had one or more chronic health condition. Home healthcare market helps patients to treat or diagnose various chronic diseases at home.

On the basis of type of devices of home healthcare, the market can be categorized as diagnostic and monitoring devices, therapeutic home healthcare devices, home mobility assist devices and medical supplies. Diagnostic and monitoring devices are further categorized as blood pressure monitors, blood glucose monitors, heart rate monitors, coagulation monitors, sleep apnea monitors, temperature monitors, pulse oximeter, pedometers, pregnancy test kits and others. Therapeutic home healthcare devices include insulin delivery devices, nebulizers, intravenous equipment, dialysis equipment and ventilator and CPAP devices. Whereas, the home mobility assist devices include wheelchairs, cranes, crutches, and others.

The home healthcare market can be categorized on the basis of services as rehabilitation services, unskilled home healthcare services, infusion therapy services, respiratory therapy services, and telehealth and telemedicine services. Diagnostic and monitoring devices lead the home healthcare market under type of devices category, due to increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases. The therapeutic home healthcare devices segment is expected to grow with the fastest rate in the coming years, due to technological advancement in therapeutic devices.

Some of the factors driving the growth of home healthcare market are rise in geriatric population, high acceptance of home based services and medical devices, increasing sedentary lifestyle, increasing healthcare expenditure, and increasing prevalence of chronic diseases. However, fatal health disorders, misguide treatment therapy, and limited geographic presence of home healthcare service providers are some of the factors restraining the growth of the home healthcare market to some extent.

Geographically, North America will be leading the global home healthcare market in the coming years, due to rise in aging population, favourable reimbursement policies, and increasing sedentary lifestyle. Moreover, Asia-Pacific is the fastest growing region in the global home healthcare market. The major reasons for the fastest growth in the region are increasing healthcare expenditure and high standards of living of the consumers in the region. Moreover, the home healthcare market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China of Asia-Pacific region.

Request Table of Contents: https://www.psmarketresearch.com/enquiry-form.php?enqid=292&title=TOC

Some of the companies operating in the home healthcare market are 3M Healthcare, Becton Dickinson and Company, Baxter International, Inc., Abbott Laboratories, Hoffmann-La Roche Ltd., Philips Healthcare, Apria Healthcare Group, Inc., Johnson & Johnson Services, Inc., Bayer AG, Eli Lilly and Company, C.R. Bard, Inc., B. Braun Melsungen AG, Carefusion Corporation, Coloplast A/S, Convatec Inc., Medtronic, Inc., and GE Healthcare.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication.  Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

 

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Medication Adherence Market, Size, Share, Growth and Demand Forecast to 2022 by P&S Market Research

The global medication adherence market is expected to grow with 17.5% CAGR during 2016 – 2022, due to growing demand for advanced medication adherence systems, and growing geriatric population. The increasing demand of mobile health (mHealth) technologies and increasing demand of personalized healthcare technologies will also drive the growth of the global medication adherence market. Among the various product offerings, the software-only offering segment is expected to witness the fastest growth during the forecast period. The global medication adherence market is growing at a significant rate.

Explore Full Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/medical-adherence

Medication Adherence Market

The information and data in the publication “Global Medication Adherence Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by product, and class or medication. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online, and offline research.

Request for Report Sample: https://www.psmarketresearch.com/market-analysis/medical-adherence/report-sample

Medication non-adherence is one of the most crucial problems in the healthcare industry, posing a strong financial impact on the global population. For healthcare employers, insurers, and patients, medication non-adherence significantly increases healthcare costs of disease-related complications. For pharmaceutical companies, pharmacy benefit managers, and pharmacies, medication non-adherence significantly grind down the profit due to non-adhering of medications by the patients. The growing interest of pharmaceutical companies and healthcare providers on medication adherence poses a greater influence on promoting better healthcare outcomes.

The restraints associated with the growth of the global medication adherence market include privacy and security issues in the EHR and e-prescribing based medication adherence; and inadequate healthcare infrastructure in developing economies.

Some of the key companies operating in the global medication adherence market include Koninklijke Philips N.V., Qualcomm Incorporated, Proteus Digital Health Inc., AdhereTech Inc., Omnicell, Inc., Adherence Solutions LLC, SMRxT, McKesson Corporation, and DrFirst.

GLOBAL MEDICATION ADHERENCE MARKET SEGMENTATION

By Product

  • Hardware Centric Offering
    • Devices
      • Smart Pill Bottle
      • Automated Dispensing System
      • Electronic Tray
      • Others
    • Packaging
      • Single Dose
      • Multi Dose
    • Software Centric Offering
      • Mobile Apps
      • Others

 

By Class or Medication

  • Cardiovascular
  • Diabetes
  • Oncology
  • CNS
  • Respiratory
  • Rheumatology
  • Gastrointestinal
  • Others

By Geography

  • North America
    • S.
    • Canada
    • Rest of North America
  • Europe
    • K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • Japan
    • India
    • Rest of Asia
  • Rest of the World (RoW)

 

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-Free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Diabetic Nephropathy Market Industry, Development and Demand Forecast to 2020

The increase in research and development funds for drug discovery followed by growing awareness of kidney-related disorders, and diabetes are the major factors driving the expansion of the global diabetic nephropathy market. Globally, many programs are organized by the American Diabetes Association to prevent diabetes, create awareness among vulnerable populations, and ensure that all patients with diabetes are able to get the best care, information and treatment about diabetes management. Thus, the increased awareness about diabetic nephropathy drugs is a new trend that is expected to influence the growth of the global diabetic nephropathy market during the forecast period.

To know more visit: https://www.psmarketresearch.com/market-analysis/diabetic-nephropathy-market

Diabetic Nephropathy Market

Diabetes is a disease defined by high blood sugar level, caused by inappropriate functioning of the pancreas (the organ which secretes insulin in the body). Nephropathy means kidney impairment or damage. Diabetic nephropathy is the impairment or damage to the kidneys caused by diabetes. It is a disease which affects the kidney glomerulus and one of the most major issues for diabetic patients. Not only the person with diabetes has to undergo kidney impairment, but also the acute cases of diabetic nephropathy could lead to kidney miscarriage. The disease affects the kidneys in a way that makes it futile. Progressive growth in proteinuria and failure in renal function, hypertension, and high risk of cardiovascular disease are the major side effects of chronic diabetic nephropathy. Blood pressure (BP) control is necessary in minimizing the progression of diabetic nephropathy. Irrespective of the agent used, lower blood pressure in type II diabetics could slow down the start and progression of diabetic nephropathy.

On the basis of treatment, the global diabetic nephropathy market is segmented by disease modifying therapies into, diuretics, angiotensin-converting enzyme inhibitors, antioxidant inflammation modulator, angiotensin receptor blockers, renin inhibitors, calcium channel blockers, connective tissue growth factor inhibitors, monocyte chemo attractant proteins inhibitor, monocyte chemo attractant proteins inhibitor, G protein-coupled receptors and endothelin (a receptor antagonist).

There are very few symptoms in the initial stages of diabetic nephropathy; however proteinuria, leg swelling, nocturia, nausea/vomiting and high BP are the common signs and symptoms of advanced diabetic nephropathy. Blood pressure control and glycemic control and are the two major treatments used to limit the development of diabetic nephropathy.

Increasing prevalence of diabetes in various parts of Europe, and the rise in healthcare spending for diabetes treatment are enhancing the growth of European diabetic nephropathy market. Asia-Pacific dominates the global diabetic nephropathy market, owing to an upsurge in diabetic population in several countries such as the Southeast Asian countries and Japan. As per the International Diabetes Federation (IDF), developing countries such as China and India, are anticipated to have maximum number of diabetes mellitus patients, in comparison to developed countries such as Germany and the U.S.

Various government programs are spreading cognizance about diabetes and related renal complications in North America. For example, the National Kidney Disease Education Program (NKDEP) is one of the most important programs organized by the U.S. government, for growing awareness about the various kidney diseases.

Lack of complete therapeutic management for diabetic nephropathy, longer approval time for drugs as well as, harsh regulatory requirements are hampering the market growth of global diabetes nephropathy market.

Request for Table of Content: https://www.psmarketresearch.com/enquiry-form.php?enqid=271&title=TOC

Some of the major competitors in the global diabetic nephropathy market are Novartis AG, Merck & Co., Inc., Pfizer Inc., Abbott India Limited, Sanofi, Eli Lilly and Company, Reata Pharmaceuticals, Inc., Bayer AG, AbbVie Inc., and Mitsubishi Tanabe Pharma Corporation.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication.  Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

 

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Computed Tomography Market Industry, Analysis, Growth and Forecast to 2022

The global CT market is growing at a significant rate, due to increasing healthcare expenditure, and growing geriatric population. The increasing prevalence of chronic diseases and improving healthcare infrastructure in developing countries are also driving the growth of the global computed tomography market. However, the factors such as stringent regulatory requirements for the approval of CT devices, and side effects of ionization radiation are inhibiting the growth of the global market.

Explore Report with Detailed TOC at: https://www.psmarketresearch.com/market-analysis/computed-tomography-market

Computed Tomography Matket

Computed tomography (CT) is an imaging procedure, which uses special x-ray equipment to provide detailed images of internal organs, blood vessels, soft tissues and bones. It is also known as CAT scanning (computerized axial tomography). It provides cross-sectional images in multiple planes. It helps in diagnosis of cancer, circulatory conditions and disorders (coronary artery disease, blood clots, and blood vessel aneurysms), kidney and bladder stone, spinal conditions, inflammatory diseases (ulcerative colitis and sinusitis), and injuries to head, skeletal system and internal organs.

Geographically, North America dominated the global market of CT in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth, at a CAGR of 5.8%, during the forecast period.

Some of the key companies operating in the global CT market include Hitachi Ltd., Siemens AG, Toshiba Corporation, Samsung, General Electric Company, and Koninklijke Philips N.V.

Global Computed Tomography (CT) Market Segmentation

By Slice Type

  • High Slice Type
  • Mid Slice Type
  • Low Slice Type

By End User

  • Diagnostic Center
  • Hospital
  • Others

By Geography

  • North America
    • S.
    • Canada
    • Rest of North America
  • Europe
    • K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia
  • Rest of the World (RoW)

 

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Deep
Assistant – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Gastrointestinal Over the Control (OTC) Drugs Market Analysis, Development, Growth and Demand Forecast to 2020

The gastrointestinal over the control drugs market is growing at a significant rate mainly due to increase in patient population. Strategic alliances are one the major trends that can be seen in the gastrointestinal over the control drugs market and is supporting the market to grow at a more considerable rate.

To know more visit: https://www.psmarketresearch.com/market-analysis/gastrointestinal-otc-drugs-market

Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are available without any prescription from the doctor. Over the counter drugs are chosen by regulatory agencies very carefully so as to ensure their efficacy and safety.

The gastrointestinal over the control drugs can also be bought without any prescription of doctor. The gastrointestinal over the control drugs are used for indications such as vomiting, gastro esophageal reflux disease (GERD), diarrhea, flatulence and constipation. The over the control drugs are not compelled by regulatory guidelines, but they need to fulfill the drug monograph of a certain country.

On the basis of types of product, the gastrointestinal over the control drugs market can be categorized as laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti diarrheals, proton pump inhibitors, h2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory and anti emetics. On the basis of indication, the gastrointestinal over the control drugs market can be categorized as nausea due to motion sickness, heartburn, flatulence, diarrhea and constipation.

High expenditure on advertisement is one of the major factors restraining the growth of the gastrointestinal over the control drugs market.

Many countries have applied regulations regarding the gastrointestinal over the control drugs in their countries. In Canada, an intermediate category exist which states that non prescription stuffs must be kept in a store room, behind the counter, or on a shelf visible to the pharmacist and the stuffs include weak muscle relaxants, codeine products, and antihistamines. In the Netherlands, categories of non prescription drugs have been made as uitsluitend recept, uitsluitend apotheek, uitsluitend apotheek of drogist and algemene verkoop. The uitsluitend apotheek drug can be on the shelves like any other product. Uitsluitend apotheek of drogist can be sold at drugstores and it includes only a small selection of drugs such as cough medicine and painkillers. Algemene verkoop drugs can be sold at gas stations and supermarkets, and it includes drugs with minimal risk to the public such as cetirizine, paracetamol, loperamide, and 200 mg ibuprofen.

In the U.S., the Food and Drug Administration regulates the manufacturing and sale of over the control drugs. The Food and Drug Administration compels that all new drugs should obtain a new drug application (NDA) before it enters throughway, but the act excuse any drug which is recognized as effective and safe for the requirement. Some of the over the control drugs approved in the U.S. are anti-microbial, sunscreens, anti fungal products, and internal and external analgesics. In the U.K., Medicines Regulations 2012 governs the medication. Medication in the country is categorized as a general sales list, prescription only medication and pharmacy medicines.

Request for Table of Content: https://www.psmarketresearch.com/enquiry-form.php?enqid=242&title=TOC

Some of the competitors in the gastrointestinal over the control drugs market are Procter & Gamble, GlaxoSmithKline Pharmaceuticals Limited, Purdue Pharma L.P., Bayer AG, Boehringer Ingelheim GmbH, Johnson & Johnson Private Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Reckitt Benckiser Group plc, C.B. Fleet Company, Inc., Perrigo Company plc, Sanofi, OMEGA SA, Abbott Laboratories, and Nestle SA.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication.  Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

 

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Global Corrugated Packaging Market Analysis, Development and Demand Forecast to 2020 by P&S Market Research

The global corrugated packaging market was valued at $150.1 billion in 2014, and it is expected to grow at a CAGR of 4.6% during the forecast period 2015 – 2020. The global corrugated packaging market is increasing due to booming E-commerce, along with the increasing industrial production in the developing countries.  The increasing urbanization and growing disposable income are further encouraging the growth of non-durable consumer goods, which in turn is up surging the growth of the corrugated packaging market.

The corrugated packaging market by application covers corrugated packaging for processed food, personal and household care products, beverages, electrical and electronic goods, chemicals, glassware and ceramics, fresh food and produce, paper products, tobacco, and others. The others application market for corrugated packaging includes furniture, footwear, and apparel.

Explore Report Description with Detailed TOC on “Global Corrugated Packaging Market” at: https://www.psmarketresearch.com/market-analysis/corrugated-packaging-market

The information and data in the publication “Corrugated Packaging Market Size, Share, Development, Growth and Demand Forecast to 2020 – Industry Insights by Application (Processed Food, Personal Care and Household Products, Beverages, Electrical and Electronics Goods, Chemicals, Glassware and Ceramics, Fresh Food and Produce, Paper Products, Tobacco, Others)” represent the research and analysis of data from various primary and secondary sources. A bottom-up approach has been used to calculate the global corrugated packaging market by application. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interact with leading companies of the concerned domain to substantiate every value of data presented in this report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online and offline research.

The emerging market in Latin America and Asia-Pacific offers significant growth opportunity for the corrugated packaging market. Large population, along with growing consumer awareness towards health and environment has increased the market penetration of corrugated packaging in the non-durable products segment. The growth of e-commerce in China, India, and Brazil has boosted the demand of corrugated packaging material in the recent years. With many new international e-commerce players entering the developing countries, the market for e-commerce is expected to increase further during the forecast period. However, limitation of corrugated materials, such as low strength, low durability, and very low water resistance properties, are hindering the growth of the corrugated packaging market. The global corrugated packaging market is going through number of mergers and acquisitions, which indicates strong sustainability in the corrugated packaging market.

Ask Sample Pages on “Global Corrugated Packaging Market” at: https://www.psmarketresearch.com/enquiry-form.php?enqid=509&title=Report%20sample

Asia-Pacific was the largest regional market of corrugated packaging, with market share of 47.5% in 2014. Asia-Pacific and developing countries of Latin America are among the fastest growing markets for corrugated packaging, owing to the increasing industrial production in these regions. The Asia-Pacific region is expected to increase its share by more than half of the total corrugated packaging market, by the end of 2020.

The major players in the corrugated packaging market include Nine Dragons Paper (Holdings) Limited, RockWest Company, International Paper Company, Lee & Man Paper Manufacturing Ltd., Georgia-Pacific Equity Holdings LLC, Smurfit Kappa Group, Mondi Group, Packaging Corporation of America, Oji Holdings Corporation, and DS Smith PLC.

Browse Related Research by P&S Market Research at: https://www.psmarketresearch.com/industry-report/consumer-products

 CORRUGATED PACKGING MARKET SEGMENTATION

Corrugated Packaging Market by Application

  • Processed food
  • Personal and household care products
  • Beverages
  • Electrical and electronic goods
  • Chemicals
  • Glassware and ceramics
  • Fresh food and produce
  • Paper products
  • Tobacco
  • Others

 GEOGRAPHICAL SEGMENTATION

Corrugated Packaging Market by Region

  • North America
    • The U.S.
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • The U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Rest of Asia Pacific
  • Rest of the World (ROW)
    • Brazil

 

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Companion Diagnostics Market Analysis, Development, Growth and Demand Forecast to 2020

Companion diagnostics offers a set of tools that facilitates biological and clinical information to the pharmaceutical companies that they have to overcome. Companion diagnostics help physicians to improve the treatment decisions for the patients depending on their response to current treatments. Companion diagnostics approach to medication is transforming the healthcare industry by eliminating unfavorable reactions, improving treatment outcomes, and reducing the cost and time difficulties associated with conventional methods of medication. Companion diagnostic is basically a bio-analytical method designed to evaluate whether the patient will respond favorably to the specific medical treatment or not. The market is fully dependent on discovery of biomarkers, and research and development of new drugs. With the surge in research and development of targeted rehabilitations and innovation of new biomarkers for a range of conditions, the global companion diagnostics market is growing at healthy rate.

For more information visit: https://www.psmarketresearch.com/market-analysis/companion-diagnostics-market

Companion Diagnostics Market

Several targeted drugs in association with a companion diagnostics test are developed and have reached to large numbers of consumers. Large and small biopharmaceutical companies actively develop drug diagnostic combination products which are fast to surpass traditional drugs, favoring the concept of one-size-fits-all. U.S. Food and Drug Administration (FDA) have approved companion diagnostics for lung colorectal, breast, and melanoma. Some of the companion diagnostics devices are erbitux vectibix, lynparza, gilotrif, herceptin, exjade, gleevec, zelboraf and tarceva.

On the basis of technology, the companion diagnostics market can be bifurcated as immunohistochemistry test (IHC), polymerase chain reaction tests (PCR), and in situ hybridization tests (ISH). Based on the application, the global companion diagnostics market can be categorized as breast cancer, gastric cancer, colorectal cancer, melanoma, and lung cancer. Further on the bases of end users, the global companion diagnostics market can be categorized as reference laboratories and pharmaceutical companies.

Regulatory agencies, such as FDA, are encouraging the use of companion diagnostics in the development and use of prescribed drugs. The guidance started in 2004 in the form of FDA critical path initiative and was followed by the drug diagnostic co-development concept in 2005.

Increasing scope for companion diagnostics and emerging technologies, such as next-generation sequencing (NGS), are some of the major opportunities for the global companion diagnostics market. Some of the major factors driving the growth of global companion diagnostics market are growing adoption of companion diagnostics by pharmaceutical companies and reference laboratories, regulatory bodies encouraging implementation of companion diagnostics, increasing demand and developmental of personalized medicine and rising demand for targeted cancer treatment.

Reimbursement scenario, effect of influence of advocacy groups and clinical societies, and extended developmental and approval phases are some of the factors that are restraining the growth of global companion diagnostics market. One of the major challenges for the companion diagnostics market is co-ordination in the development of drugs and diagnostics together.

Request for Table of Content:  https://www.psmarketresearch.com/enquiry-form.php?enqid=122&title=TOC

North America had the largest companion diagnostics market because of the increasing incidence of cancer and increased healthcare awareness. Whereas, Asia-Pacific is the fastest growing market of companion diagnostics owing to the strengthening healthcare services and increasing medical tourism in developing countries such as India and China.

Some of the major competitors in companion diagnostics market are Thermo Fisher Scientific, Inc., Ventana Medical Systems Inc, Biogenex Laboratories Inc, Agilent Technologies, Leica Microsystems GmbH, Abbott Laboratories, Inc., Danaher Corporation, Myriad Genetics, Life Technologies, Inc., BioMerieux SA, Roche Diagnostics, and GE Healthcare.

 

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports; business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

US/ Canada Toll-Free: 1-888-778-7886

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

CDSS Market Analysis, Development and Demand Forecast to 2022

The global CDSS Market was valued at $410.5 million in 2015, and it is expected to grow at a CAGR of 21.5% during 2016-2022. Among the various products, the integrated CDSS segment is expected to witness the fastest growth, CAGR of 22.4%, during the forecast period. The global CDSS market is growing at a significant rate, due to growing demand for advanced healthcare information systems, and growing investments by HIT players. In addition, the growing need for remote patient monitoring services and increasing support from government organizations is also driving the growth of the global CDSS market.

Explore Report With Detailed TOC: https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market

CDSS Market by P&S Market Research

The information and data in the publication “Global CDSS Market Size, Share, Development, Growth and Demand Forecast to 2022” represent the research and analysis of data from various primary and secondary sources. The bottom-top approach has been used to calculate the global market size by product, application, model, delivery model, component and healthcare provider entity capacity. The market numbers for countries are obtained through top-down approach. P&S Market Research analysts and consultants interacted with the authorities from leading companies of the concerned domain, to substantiate every value of data presented in the report. The company bases its primary research on discussions with prominent professionals and analysts in the industry, which is followed by informed and detailed, online, and offline research.

Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/clinical-decision-support-system-market/report-sample

CDSSs are computer-based information systems that are designed to assist healthcare providers in the implementation of clinical guidelines at the point of care. The system uses patient information to provide evidence-based treatment recommendation for healthcare providers and delivers better clinical outcomes. CDSS are often incorporated within electronic health records (EHR) and integrated with other computer-based functions that provide patient-care summary reports, and feedback on quality indicators.

The factors, such as privacy and security issues, high capital expenditure and maintenance requirement, and inadequate healthcare infrastructure in developing economies are inhibiting the growth of the global market. The increasing popularity of CDSS in healthcare facilities is the key trend observed in the global CDSS market.

Browse Related Research: https://www.psmarketresearch.com/industry-report/healthcare

Geographically, North America dominated the global market of CDSS in 2015; whereas the Asia-Pacific market is expected to witness the fastest growth at a CAGR of 23.2%, during the forecast period.

Some of the key companies operating in the global CDSS Market include Cerner Corporation, RELX Group PLC, Epic Systems Corporation, General Electric Company, McKesson Corporation, Zynx Health Incorporated, International Business Machine Corporation and Siemens AG.

GLOBAL CDSS MARKET SEGMENTATION

By Product

  • Integrated CDSS Solutions
  • Standalone CDSS Solutions

By Application

  • Drug Dosing Support
  • Clinical Guidelines
  • Clinical Reminders
  • Drug-Drug Interactions
  • Drug Allergy Alerts
  • Others

By Model

  • Knowledge-based CDSS Solutions
  • Non-Knowledge-Based CDSS Solutions

By Mode of Delivery

  • On-Premises
  • Web-Based
  • Cloud-Based

By Component

  • Software
  • Hardware
  • Services

 

By Healthcare Provider Entity Capacity

  • Less than 100 Beds
  • 100–199 Beds
  • 200–299 Beds
  • 300–399 Beds
  • 400–499 Beds
  • More than 500 Beds

 

By Geography

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Western Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Western Europe
  • Central & Eastern Europe
    • Russia
    • Rest of Central & Eastern Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa

 

 

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:

Deep

Assistant – Client Partner

347, 5th Ave. #1402

New York City, NY – 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com